HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Vietnam
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS

    Tag: #Global Trends

    Hacking group claims 1.3 terabyte data breach at Novo Nordisk following failed $25 million extortion attempt

    17/06/2026 Published by Pharma Biz

    A cyber extortion group has claimed to have exfiltrated over a terabyte of proprietary data from Danish pharmaceutical behemoth Novo... Read more

    Category: Uncategorized
    Tags: #Global Trends

    FDA staff reviewers back Moderna’s flu shot data for accelerated older adult approval pathway

    17/06/2026 Published by Pharma Biz

    U.S. Food and Drug Administration staff reviewers announced on Tuesday that immunogenicity data tracking an active immune response to Moderna’s... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Moderna eyes manufacturing investments in Germany, targeting BioNTech’s planned facility closures

    17/06/2026 Published by Pharma Biz

    Moderna Chief Executive Officer Stephane Bancel told the German business daily Handelsblatt on Wednesday (June 17, 2026) that the United... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Edgewise heart drug clears Phase 2 trial milestone but faces investor skepticism over competitive edge

    17/06/2026 Published by Pharma Biz

    Colorado-based biotechnology firm Edgewise Therapeutics has announced that its investigational cardiovascular compound, EDG-7500, successfully met the primary objectives of its... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Lilly’s Jaypirca combination slashes progression risk by 45% in pivotal Phase 3 BRUIN CLL-322 leukemia trial

    16/06/2026 Published by Pharma Biz

    Eli Lilly and Company has officially announced definitive data from its global Phase 3 BRUIN CLL-322 clinical trial. The landmark... Read more

    Category: Uncategorized
    Tags: #Global Trends

    FDA accepts SK Life Science’s New Drug Application for review of cenobamate oral suspension

    16/06/2026 Published by Pharma Biz

    SK Life Science, Inc. (a Paramus, New Jersey-based biopharmaceutical enterprise and a subsidiary of South Korea's SK Biopharmaceuticals Co., Ltd.)... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Novartis India launches Pluvicto, the nation’s first approved radioligand therapy for advanced prostate cancer

    16/06/2026 Published by Pharma Biz

    Novartis India has officially announced the commercial launch of Pluvicto, marking the country’s premier regulatory-approved radioligand therapy (RLT) indicated for... Read more

    Category: Uncategorized
    Tags: #Global Trends

    FDA clears Merck’s Keytruda and Welireg combination as adjuvant treatment for clear cell renal cell carcinoma

    16/06/2026 Published by Pharma Biz

    Merck & Co. (operating as MSD outside the United States and Canada) has secured formal marketing approval from the U.S.... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Simcere Pharmaceutical and Stanford Medicine forge research alliance to pioneer first-in-class IPF therapies

    16/06/2026 Published by Pharma Biz

    Simcere Pharmaceutical Group has formalized a strategic research collaboration agreement with Stanford Medicine to discover and develop novel therapeutic interventions... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Posts pagination

    Previous page Page 1 Page 2 Page 3 Page 4 … Page 72 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved